Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2024 Oct 27;196(36):E1247-E1248.
doi: 10.1503/cmaj.240408-f.

Teigne de la peau glabre ou eczéma marginé de Hebra réfractaires causés par Trichophyton indotineae

[Article in French]
Affiliations

Teigne de la peau glabre ou eczéma marginé de Hebra réfractaires causés par Trichophyton indotineae

[Article in French]
Ellen G Avery Dr Rer Nat et al. CMAJ. .
No abstract available

PubMed Disclaimer

Conflict of interest statement

Intérêts concurrents :: Julianne Kus préside le comité scientifique de mycologie de l’Institute for Quality Management in Healthcare. Aucun autre intérêt concurrent n’a été déclaré.

Figures

Figure 1:
Figure 1:
Infection de teigne de la peau glabre causée par Trichophyton indotineae.

References

    1. Caplan AS, Chaturvedi S, Zhu Y, et al. Notes from the field: first reported U.S. cases of tinea caused by Trichophyton indotineae — New York City, December 2021–March 2023. MMWR Morb Mortal Wkly Rep 2023;72:536–7. - PMC - PubMed
    1. Gupta AK, Venkataraman M, Hall DC, et al. The emergence of Trichophyton indotineae: implications for clinical practice. Int J Dermatol 2023;62:857–61. - PubMed
    1. Uhrlaß S, Verma SB, Graser Y, et al. Trichophyton indotineae — an emerging pathogen causing recalcitrant dermatophytoses in India and worldwide — a multidimensional perspective. J Fungi (Basel) 2022;8:757. - PMC - PubMed
    1. Khurana A, Agarwal A, Agrawal D, et al. Effect of different itraconazole dosing regimens on cure rates, treatment duration, safety, and relapse rates in adult patients with tinea corporis/cruris: a randomized clinical trial. JAMA Dermatol 2022;158:1269–78. - PMC - PubMed
    1. Posso-De Los Rios CJ, Tadros E, Summerbell RC, et al. Terbinafine resistant Trichophyton indotineae isolated in patients with superficial dermatophyte infection in Canadian patients. J Cutan Med Surg 2022;26:371–6. - PubMed

LinkOut - more resources